Frequent ventricular tachycardias: Antiarrhythmic drug treatment or catheter ablation?;Häufige ventrikuläre tachykardie: Antiarrhythmika oder ablation?

Herz

Volumn 30, Issue 7, 2005, Pages 613-618

  Tanner, Hildegard ^a   Hindricks, Gerhard ^a   Kottkamp, Hans ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

Antiarrhythmic drugs; Catheter ablation; Implantable cardioverter defibrillator; Ventricular tachycardia

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARTICLE; CATHETER ABLATION; DEFIBRILLATION; ELECTROPHYSIOLOGY; HEART VENTRICLE TACHYCARDIA; HUMAN; MEDICAL LITERATURE; QUALITY OF LIFE; RECURRENT DISEASE; SINUS NODE;

ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RECURRENCE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 28744459365     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-005-2749-7     Document Type: Article

References (36)

1. Arenal A, Glez-Torrecilla E, Ortiz M, et al. Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease. J Am Coll Cardiol 2003;41:81-92.
2. Bokhari F, Newman D, Greene M, et al. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004;110:112-6.
3. Borgervan der Burg AE, de Groot NM, van Erven L, et al. Long-term follow-up after radiofrequency catheter ablation of ventricular tachycardia: a successful approach? J Cardiovasc Electrophysiol 2002;13:417-23.
4. Calkins H, Epstein A, Packer D, et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy. J Am Coll Cardiol 2000;35:1905-14.
5. Connolly SJ, Hohnloser S, Dorian P, et al. Optimal Pharmacological Therapy in Implantable Cardioverter Defibrillator Patients (OPTIC) trial. Program and abstracts of the American College of Cardiology Annual Scientific Session 2005; March 6-9, 2005; Orlando, Florida. Late Breaking Clinical Trials I.
6. Delacretaz E, Stevenson WG: Catheter ablation of ventricular tachycardia in patients with coronary heart disease. Part II: Clinical aspects, limitations, and recent developments. Pacing Clin Electrophysiol 2001;24:1403-11.
7. Delacretaz E, Stevenson WG, Ellison KE, et al. Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol 2000;11:11-7.
8. Della Bella P, De Ponti R, Uriarte JA, et al. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings. Eur Heart J 2002;23:414-24.
9. Dolack GL. Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial). Cardiac Arrest in Seattle, Conventional versus Amiodarone Drug Evaluation. Am J Cardiol 1994;73:237-41.
10. Dorian P, Borggrefe M, Al-Khalidi HR, et al. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004;110:3646-54.
11. Dorian P, Newman D. Effect of sotalol on ventricular fibrillation and defibrillation in humans. Am J Cardiol 1993;72:72A-9A.
12. Gonska BD, Cao K, Schaumann A, et al. Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: results and long-term follow-up. J Am Coll Cardiol 1994;24:1506-14.
13. Greene HL. The CASCADE study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators. Am J Cardiol 1993;72: 70F-4F.
14. Hindricks G, on behalf of the MERFS Investigators. The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. Eur Heart J 1993;14:1644-53.
15. Huang SK, Tan de Guzman WL, Chenarides JG, et al. Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator. Am Heart J 1991;122:720-7.
16. Jung W, Manz M, Pizzulli L, et al. Effects of chronic amiodarone therapy on defibrillation threshold. Am J Cardiol 1992;70:1023-7.
17. Kaltenbrunner W, Cardinal R, Dubuc M, et al. Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized? Circulation 1991;84:1058-71.
18. Kim YH, Sosa-Suarez G, Trouton TG, et al. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation 1994;89:1094-102.
19. Kottkamp H, Hindricks G, Chen X, et al. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy. Circulation 1995;92:1159-68.
20. Kottkamp H, Wetzel U, Schirdewahn P, et al. Catheter ablation of ventricular tachycardia in remote myocardial infarction: substrate description guiding placement of individual linear lesions targeting noninducibility. J Cardiovasc Electrophysiol 2003;14:675-81.
21. Kou WH, Kirsh MM, Bolling SF, et al. Effect of antiarrhythmic drug therapy on the incidence of shocks in patients who receive an implantable cardioverter defibrillator after a single episode of sustained ventricular tachycardia/fibrillation. Pacing Clin Electrophysiol 1991;14:1586-92.
22. Kuhlkamp V, Mewis C, Mermi J, et al. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment. J Am Coll Cardiol 1999;33:46-52.
23. Marchlinski FE, Callans DJ, Gottlieb CD, et al. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000;101:1288-96.
24. Morady F, Harvey M, Kalbfleisch SJ, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation 1993; 87:363-72.
25. Morady F, Kadish A, Rosenheck S, et al. Concealed entrain ment as a guide for catheter ablation of ventricular tachycardia in patients with prior myocardial infarction. J Am Coll Cardiol 1991;17:678-89.
26. Pacifico A, Hohnloser SH, Williams JH, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med 1999;340:1855-62.
27. Reddy VY, Neuzil P, Taborsky M, et al. Short-term results of substrate mapping and radiofrequency ablation of ischemic ventriculartachycardia using a saline-irrigated catheter. J Am Coll Cardiol 2003;41:2228-36.
28. Scheinman MM, Huang S. The 1998 NASPE prospective catheter ablation registry. PACE 2000;23:1020-8.
29. Singer I, Al-Khalidi H, Niazi I, et al. Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators. J Am Coll Cardiol 2004;43:39-43.
30. Soejima K, Suzuki M, Maisel WH, et al. Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping. Circulation 2001;104:664-9.
31. Steinberg JS, Martins J, Sadanandan S, et al. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) study. Am Heart J 2001;142:520-9.
32. Stevenson WG, Friedman PL, Kocovic D, et al. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 1998;98: 308-14.
33. Stevenson WG, Khan H, Sager P, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993;88:1647-70.
34. Strickberger SA, Man KC, Daoud EG, et al. A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an Implantable cardioverter-defibrillator. Circulation 1997;96:1525-31.
35. Willems S, Borggrefe M, Shenasa M, et al. Radiofrequency catheter ablation of ventricular tachycardia following implantation of an automatic cardioverter defibrillator. Pacing Clin Electrophysiol 1993;16:1684-92.
36. Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic Implantable cardioverter-defibrillator. J Am Coll Cardiol 1989;13:1353-61.